REAP Financial Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Sell
14,559
-2,238
-13% -$27.2K 0.03% 159
2026
Q1
$234K Sell
16,797
-2,545
-13% -$35.7K 0.05% 116
2025
Q4
$278K Sell
19,342
-291
-1% -$4.38K 0.06% 105
2025
Q3
$313K Buy
19,633
+3,357
+21% +$55.3K 0.07% 93
2025
Q2
$288K Sell
16,276
-983
-6% -$19.1K 0.07% 97
2025
Q1
$360K Sell
17,259
-2,978
-15% -$56.5K 0.09% 81
2024
Q4
$374K Sell
20,237
-2,833
-12% -$54.5K 0.09% 86
2024
Q3
$452K Sell
23,070
-5,062
-18% -$101K 0.11% 82
2024
Q2
$552K Sell
28,132
-7,066
-20% -$134K 0.15% 78
2024
Q1
$634K Buy
35,198
+1,097
+3% +$19.9K 0.17% 81
2023
Q4
$578K Buy
+34,101
New +$678K 0.17% 79

Other funds holding BTAL

REAP Financial Group's BTAL Position: Q2 2026 in Review

REAP Financial Group reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 13% in Q2 2026, selling an estimated $27.2K and leaving 14,559 shares worth $162K. The position accounts for 0.03% of the portfolio, ranked #159.

REAP Financial Group first reported a position in BTAL in Q4 2023 and has held it in 11 quarters since. The position peaked at $634K in Q1 2024. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • REAP Financial Group held 14,559 shares of AGF US Market Neutral Anti-Beta Fund worth $162K as of Q2 2026.
  • REAP Financial Group sold 2,238 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $27.2K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.03% of REAP Financial Group's portfolio in Q2 2026, its #159 holding.
  • REAP Financial Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's AGF US Market Neutral Anti-Beta Fund position peaked at $634K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.